CraftHealth
A 3D printing platform for personalized medicines and supplements that combines multiple medications into a single daily pill with controlled release profiles.
- CEO / Founder
- Wei Jiang Goh
- Team Size
- 1-10
- Stage
- Active
- Total Funding
- $1M
- Latest Round
- Pre-Series A
- Key Investors
- Valuence Ventures, Mistletoe, Jenny Chen
Technology & Products
Key Products
CraftMake 3D Printer, CraftControl software
Technological Advantage
Integration of CraftMake 3D printer and CraftControl software enables customizable shapes, formulations, and release kinetics.
Differentiation
Value Proposition
Combines multiple medications into a single pill with controlled release profiles, enhancing patient compliance and improving treatment outcomes.
How They Differentiate
Focus on combining multiple medications into a single pill with controlled release, offering superior patient compliance.
Market & Competition
Target Customers
Healthcare providers, pharmacies, and patients requiring personalized medication regimens.
Industry Verticals
Healthcare, Pharmaceuticals, Medical Research
Competitors
Aprecia Pharmaceuticals; FabRx
Growth & Milestones
Growth Metrics
Craft Health has secured a new round of funding and signed an MOU with GMP Healthcare Ltd from the UK to offer 3D printing platform services into the UK and Europe.
Major Milestones
Development of CraftMake 3D printer, Spin-off from National University of Singapore, Collaboration with healthcare providers
Notable Customers
Singapore General Hospital, European compounding pharmacy, European CDMO, Australian compounding pharmacy, PharmaTher Holdings Ltd